Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marcelle Almeida Caminha"'
Autor:
Giselle Villa Flor Brunoro, Vitor Marcel Faça, Marcelle Almeida Caminha, André Teixeira da Silva Ferreira, Monique Trugilho, Kelly Cristina Gallan de Moura, Jonas Perales, Richard Hemmi Valente, Rubem Figueiredo Sadok Menna-Barreto
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 8, p e0004951 (2016)
BACKGROUND:The obligate intracellular protozoan Trypanosoma cruzi is the causative agent of Chagas disease, a neglected illness affecting millions of people in Latin America that recently entered non-endemic countries through immigration, as a conseq
Externí odkaz:
https://doaj.org/article/1c9e8b8b66f8457bb78103fcd700762f
Autor:
Rubem F. S. Menna-Barreto, Silvia Marinho Martins, Marcelle Almeida Caminha, Wilson Alves de Oliveira Junior, Virgínia Maria Barros de Lorena, Jonas Perales, Maria da Glória Aureliano de Melo Cavalcanti, Diogo B. Lima, Richard H. Valente, Paulo C. Carvalho
Publikováno v:
Journal of Proteomics. 194:179-190
Chagas disease, caused by the protozoan Trypanosoma cruzi, affects millions of people worldwide, especially in Latin America. Approximately 30% of the cases evolve to the chronic symptomatic stage due to cardiac and/or digestive damage, generally acc
Autor:
Wilson Alves de Oliveira Junior, Rubem F. S. Menna-Barreto, Silvia Marinho Martins, Jonas Perales, Virgínia Maria Barros de Lorena, Maria da Glória Aureliano de Melo Cavalcanti, Paulo C. Carvalho, Marcelle Almeida Caminha, Diogo B. Lima, Richard H. Valente
Publikováno v:
Data in Brief
Data in Brief, Vol 22, Iss, Pp 516-521 (2019)
Data in Brief, Vol 22, Iss, Pp 516-521 (2019)
The data presented herein is related to the article entitled ''Trypanosoma cruzi immunoproteome: calpain-like CAP5.5 differentially detected throughout distinct stages of human Chagas disease cardiomyopathy'' [1]. Electrophoretic analyses under denat
Publikováno v:
Protozoan Parasitism: From Omics to Prevention and Control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caa8356338e8a17fce4ae261c3d4ed5a
https://doi.org/10.21775/9781910190838.01
https://doi.org/10.21775/9781910190838.01
Autor:
Paulo C. Carvalho, André Teixeira da Silva Ferreira, Giselle Villa Flor Brunoro, Felipe da Veiga Leprevost, Marcelle Almeida Caminha, Rubem Figueiredo Sadok Menna-Barreto, Richard H. Valente, Jonas Perales
Publikováno v:
Journal of Proteomics. 115:58-65
Chagas disease is a neglected disease, caused by the protozoan Trypanosoma cruzi. This kinetoplastid presents a cycle involving different forms and hosts, being trypomastigotes the main infective form. Despite various T. cruzi proteomic studies, the
Autor:
Rubem Figueiredo Sadok Menna-Barreto, Marcelle Almeida Caminha, Richard H. Valente, Vitor M. Faça, André Teixeira da Silva Ferreira, Giselle Villa Flor Brunoro, Monique R.O. Trugilho, Jonas Perales, Kelly C. G. de Moura
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
PLoS Neglected Tropical Diseases, Vol 10, Iss 8, p e0004951 (2016)
PLoS Neglected Tropical Diseases
Universidade de São Paulo (USP)
instacron:USP
PLoS Neglected Tropical Diseases, Vol 10, Iss 8, p e0004951 (2016)
PLoS Neglected Tropical Diseases
Background The obligate intracellular protozoan Trypanosoma cruzi is the causative agent of Chagas disease, a neglected illness affecting millions of people in Latin America that recently entered non-endemic countries through immigration, as a conseq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee81204ea1084358b776f088be401050
Autor:
Vivian Corrêa de Almeida, Marcelle Almeida Caminha, Floriano Paes Silva Jr., Rubem Figueiredo Sadok Menna-Barreto, André Teixeira da Silva Ferreira, Jonas Enrique Aguilar Perales, Daniela Gois Beghini
Publikováno v:
Journal of Integrated OMICS. 2
Chagas´ disease is a neglected sickness endemic in Latin America, caused by the protozoa Trypanosoma cruzi. 1e current treatment for the disease is unsatisfactory, and the development of potent compounds for novel molecular targets is critical. In t